119 related articles for article (PubMed ID: 31950222)
1. Enhanced anticancer activity of combined treatment of imatinib and dipyridamole in solid Ehrlich carcinoma-bearing mice.
El-Sisi AE; Sokar SS; Ibrahim HA; Abu-Risha SE
Naunyn Schmiedebergs Arch Pharmacol; 2020 Jun; 393(6):1113-1129. PubMed ID: 31950222
[TBL] [Abstract][Full Text] [Related]
2. Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity.
El-Sisi AE; Sokkar SS; Ibrahim HA; Hamed MF; Abu-Risha SE
Fundam Clin Pharmacol; 2020 Aug; 34(4):458-475. PubMed ID: 32080901
[TBL] [Abstract][Full Text] [Related]
3. Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma.
El-Ashmawy NE; Khedr EG; Ebeid EM; Salem ML; Zidan AA; Mosalam EM
Eur J Pharm Sci; 2017 Nov; 109():525-532. PubMed ID: 28890201
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronated imatinib liposomes with hybrid approach to target CD44 and P-gp overexpressing MDR cancer: an
Negi LM; Talegaonkar S; Jaggi M; Verma AK
J Drug Target; 2019 Feb; 27(2):183-192. PubMed ID: 29972336
[TBL] [Abstract][Full Text] [Related]
5. The effect of low-dose naltrexone on solid Ehrlich carcinoma in mice: The role of OGFr, BCL2, and immune response.
Aboalsoud A; El-Ghaiesh SH; Abd Elmonem FF; Salem ML; Abdel Rahman MN
Int Immunopharmacol; 2020 Jan; 78():106068. PubMed ID: 31835085
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibition boosts the antitumor effects of Imatinib mesylate via potentiating the antiangiogenic and antimetastatic machineries.
Abd-El Fattah AA; Darwish HA; Fathy N; Shouman SA
Toxicol Appl Pharmacol; 2017 Feb; 316():123-138. PubMed ID: 28038999
[TBL] [Abstract][Full Text] [Related]
7. The synergistic effect between vanillin and doxorubicin in ehrlich ascites carcinoma solid tumor and MCF-7 human breast cancer cell line.
Elsherbiny NM; Younis NN; Shaheen MA; Elseweidy MM
Pathol Res Pract; 2016 Sep; 212(9):767-77. PubMed ID: 27493101
[TBL] [Abstract][Full Text] [Related]
8. Ursolic acid inhibits tumor angiogenesis and induces apoptosis through mitochondrial-dependent pathway in Ehrlich ascites carcinoma tumor.
Saraswati S; Agrawal SS; Alhaider AA
Chem Biol Interact; 2013 Nov; 206(2):153-65. PubMed ID: 24051192
[TBL] [Abstract][Full Text] [Related]
9. The ponatinib/gossypol novel combination provides enhanced anticancer activity against murine solid Ehrlich carcinoma via triggering apoptosis and inhibiting proliferation/angiogenesis.
El-Lakkany NM; Elkattan HH; Elsisi AE
Toxicol Appl Pharmacol; 2021 Dec; 432():115767. PubMed ID: 34699866
[TBL] [Abstract][Full Text] [Related]
10. Potential cardioprotective and anticancer effects of carvedilol either free or as loaded nanoparticles with or without doxorubicin in solid Ehrlich carcinoma-bearing mice.
Zidan A; El Saadany AA; El Maghraby GM; Abdin AA; Hedya SE
Toxicol Appl Pharmacol; 2023 Apr; 465():116448. PubMed ID: 36921847
[TBL] [Abstract][Full Text] [Related]
11. Thymoquinone chemosensitizes human colorectal cancer cells to imatinib via uptake/efflux genes modulation.
Thabet NA; El-Khouly D; Sayed-Ahmed MM; Omran MM
Clin Exp Pharmacol Physiol; 2021 Jun; 48(6):911-920. PubMed ID: 33783002
[TBL] [Abstract][Full Text] [Related]
12. Antagonist activity of the antipsychotic drug lithium chloride and the antileukemic drug imatinib mesylate during glioblastoma treatment in vitro.
Aras Y; Erguven M; Aktas E; Yazihan N; Bilir A
Neurol Res; 2016 Sep; 38(9):766-74. PubMed ID: 27367429
[TBL] [Abstract][Full Text] [Related]
13. Oxamate potentiates taxol chemotherapeutic efficacy in experimentally-induced solid ehrlich carcinoma (SEC) in mice.
El-Sisi AE; Sokar SS; Abu-Risha SE; El-Mahrouk SR
Biomed Pharmacother; 2017 Nov; 95():1565-1573. PubMed ID: 28950656
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cancer cell line.
Agrawal SS; Saraswati S; Mathur R; Pandey M
Life Sci; 2011 Aug; 89(5-6):147-58. PubMed ID: 21684292
[TBL] [Abstract][Full Text] [Related]
15. The Potency of Red Seaweed (
Wardani G; Farida N; Andayani R; Kuntoro M; Sudjarwo SA
Pharmacognosy Res; 2017; 9(3):282-286. PubMed ID: 28827971
[TBL] [Abstract][Full Text] [Related]
16. Effect of hesperidin on mice bearing Ehrlich solid carcinoma maintained on doxorubicin.
Khedr NF; Khalil RM
Tumour Biol; 2015 Dec; 36(12):9267-75. PubMed ID: 26099723
[TBL] [Abstract][Full Text] [Related]
17. The effect of celecoxib and its combination with imatinib on human HT-29 colorectal cancer cells: Involvement of COX-2, Caspase-3, VEGF and NF-κB genes expression.
Atari-Hajipirloo S; Nikanfar S; Heydari A; Noori F; Kheradmand F
Cell Mol Biol (Noisy-le-grand); 2016 Feb; 62(2):68-74. PubMed ID: 26950454
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-2 treatment effect on imatinib pharmacokinetic, P-gp and BCRP expression in mice.
Hosten B; Abbara C; Cibert M; Petit B; Farinotti R; Gonin P; Bonhomme-Faivre L
Anticancer Drugs; 2010 Feb; 21(2):193-201. PubMed ID: 20016370
[TBL] [Abstract][Full Text] [Related]
19. [The Mechanism of Combination using mTORC1/2 Inhibitor and Imatinib to Suppress Cell Proliferation of Ph
Wu JH; Shi FF; Gong YP; Shi R
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):216-220. PubMed ID: 28612529
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil potentiates the antitumor activity of cisplatin by induction of apoptosis and inhibition of proliferation and angiogenesis.
El-Naa MM; Othman M; Younes S
Drug Des Devel Ther; 2016; 10():3661-3672. PubMed ID: 27895461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
